Bio-Techne (TECH) Current Deferred Tax Assets (2010 - 2015)
Bio-Techne (TECH) posted quarterly Current Deferred Tax Assets of $11.5 million for Q4 2015, down 12.05% year-over-year from $13.1 million in Q4 2014, and down 30.96% quarter-over-quarter from $16.7 million in Q3 2015.
Analysis
Bio-Techne (TECH) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Bio-Techne's Current Deferred Tax Assets history runs 5 years deep, the most recent figure standing at $11.5 million for Q4 2015.
- In Q4 2015, Current Deferred Tax Assets fell 12.05% year-over-year to $11.5 million; the TTM figure through Dec 2015 stood at $11.5 million (down 12.05% YoY), while the FY2015 annual figure was $11.5 million, up 19.62% from the prior year.
- Current Deferred Tax Assets for Q4 2015 stood at $11.5 million, down from $16.7 million in the prior quarter.
- The five-year high for Current Deferred Tax Assets was $19.1 million in Q3 2014, with the low at $5.8 million in Q2 2011.
- The 4-year median for Current Deferred Tax Assets is $11.2 million (2011), against an average of $11.2 million.
- The sharpest annual moves came in 2011 and 2014: Current Deferred Tax Assets plunged 56.67% in 2011, then jumped 100.99% in 2014.
- Bio-Techne's Current Deferred Tax Assets stood at $12.9 million in 2011, then slipped by 23.55% to $9.9 million in 2013, then jumped by 32.52% to $13.1 million in 2014, then declined by 12.05% to $11.5 million in 2015.
- Business Quant data shows TECH's Current Deferred Tax Assets at $11.5 million in Q4 2015, $16.7 million in Q3 2015, and $11.5 million in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 11.51 Mn |
| Sep 30, 2015 | 16.68 Mn |
| Jun 30, 2015 | 11.51 Mn |
| Mar 31, 2015 | 11.73 Mn |
| Dec 31, 2014 | 13.09 Mn |
| Sep 30, 2014 | 19.15 Mn |
| Jun 30, 2014 | 9.62 Mn |
| Mar 31, 2014 | 8.51 Mn |
| Dec 31, 2013 | 9.88 Mn |
| Sep 30, 2013 | 9.53 Mn |
| Dec 31, 2011 | 12.92 Mn |
| Sep 30, 2011 | 6.73 Mn |
| Jun 30, 2011 | 5.80 Mn |
| Mar 31, 2011 | 10.84 Mn |
| Dec 31, 2010 | 12.12 Mn |
| Sep 30, 2010 | 12.63 Mn |
| Jun 30, 2010 | 13.38 Mn |